Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/0950 stock hub

HKG/0950 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/0950is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

683M

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/0950

In the news

Latest news · HKG/0950

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E7.4

P25 10.7P50 17.9P75 38.5

ROE2.9

P25 -14.7P50 2P75 9.4

ROIC4.1

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/0950 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

HKD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	1,094
Employees Change	72%
Employees Change Percent	7.05
Enterprise value	HKD 497.8M
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG5438W1116
Last refreshed	2026-05-10
Market cap	HKD 683M
Price	HKD 1.16
Price currency	HKD
Rev Per Employee	1,312,595.98x
Sector	Healthcare
Sic	2834
Symbol	hkg/0950
Website	https://www.leespharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	13.46%
EV Earnings	5.42x
EV/EBIT	4.59x
EV/EBITDA	2.42x
EV/FCF	1.87x
EV/Sales	0.35x
FCF yield	38.98%
P/B ratio	0.36x
P/E ratio	7.43x
P/S ratio	0.48x
PE Ratio10 Y	20.88x
PE Ratio3 Y	9.91x
PE Ratio5 Y	28.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.68%
EBITDA Margin	13.79%
FCF margin	18.54%
Gross margin	50.81%
Gross Profit	HKD 729.6M
Gross Profit Growth	-4.36%
Gross Profit Growth Q	-8.26%
Gross Profit Growth3 Y	5.72%
Gross Profit Growth5 Y	2.79%
Net Income	HKD 91.9M
Net Income Growth	-1.25%
Net Income Growth Q	-19.16%
Net Income Growth Years	0%
Net Income Growth3 Y	13.39%
Net Income Growth5 Y	18.75%
Pretax Margin	5.08%
Profit Margin	6.4%
Profit Per Employee	HKD 84,038
Profitable Years	19
ROA	2.27
Roa5y	1.37
ROCE	4.73
ROE	2.93
Roe5y	19.41
ROIC	4.12
Roic5y	2.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-13.78%
Cagr15y	-4.61%
Cagr1y	-9.58%
Cagr20y	12.09%
Cagr3y	-8.51%
Cagr5y	-22.34%
Div CAGR10	-8.04%
Div CAGR3	31.04%
Div CAGR5	-4.95%
EPS Growth	-1.27
EPS Growth Q	-19.19
EPS Growth Years	0
EPS Growth3 Y	13.38
EPS Growth5 Y	18.74
FCF Growth	34.44%
FCF Growth Q	-38.98%
FCF Growth3 Y	36.97%
FCF Growth5 Y	42.36%
OCF Growth	37.56%
OCF Growth Q	-18.82%
OCF Growth10 Y	4.28%
OCF Growth3 Y	36.81%
OCF Growth5 Y	36.41%
Revenue Growth	2.57x
Revenue Growth Q	-0.06x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	6.19x
Revenue Growth5 Y	5.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.47
Assets	HKD 3.5B
Cash	HKD 349.9M
Current Assets	HKD 1.2B
Current Liabilities	HKD 1.1B
Debt	HKD 310.3M
Debt EBITDA	HKD 1.49
Debt Equity	HKD 0.16
Debt FCF	HKD 1.17
Equity	HKD 1.9B
Interest Coverage	10.17
Liabilities	HKD 1.6B
Long Term Assets	HKD 2.3B
Long Term Liabilities	HKD 433.4M
Net Cash	HKD 39.6M
Net Cash By Market Cap	HKD 5.8
Net Debt EBITDA	HKD -0.2
Net Debt Equity	HKD -0.02
Net Debt FCF	HKD -0.15
Tangible Book Value	HKD 1.7B
Tangible Book Value Per Share	HKD 2.95
WACC	5.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.03
Inventory Turnover	2.17
Net Working Capital	HKD -87.6M
Quick ratio	0.48
Working Capital	HKD 39.1M
Working Capital Turnover	HKD 54.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	HKD 0.05
Dividend Years	19
Dividend Yield	3.88%
Ex Div Date	2026-05-27
Last Dividend	HKD 0.02
Payout Frequency	Semi-Annual
Payout Ratio	30.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-77.3%
1Y total return	-9.57%
200-day SMA	1.68
3Y total return	-23.42%
50-day SMA	1.26
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.75%
All Time High	15.4
All Time High Change	-92.47%
All Time High Date	2015-05-26
All Time Low	0.1
All Time Low Change	1,060%
All Time Low Date	2005-08-12
ATR	0.05
Beta	0.57
Beta1y	0.63
Beta2y	0.26
Ch YTD	-23.68
High	1.16
High52	2.7
High52 Date	2025-09-16
High52ch	-57.04%
Low	1.12
Low52	1.09
Low52 Date	2026-04-30
Low52ch	6.42%
Ma50ch	-8.01%
Price vs 200-day SMA	-31.08%
RSI	43.93
RSI Monthly	41.58
RSI Weekly	32.45
Sharpe ratio	0.03x
Sortino ratio	0.16
Total Return	3.85%
Tr YTD	-23.68
Tr15y	-50.76%
Tr1m	-4.13%
Tr1w	4.51%
Tr3m	-22.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 110.3M
Operating Income Growth	-17.01
Operating Income Growth Q	-33.98
Operating Income Growth3 Y	15.98
Operating Income Growth5 Y	0.95
Operating margin	7.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	248,191,756%
Net Borrowing	63,258,000
Shares Insiders	11.8%
Shares Institutions	7.01%
Shares Out	588,835,343
Shares Qo Q	0.06%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 265.8M
Average Volume	679,375x
Bv Per Share	3.47
CAPEX	HKD -66.6M
Ch10y	-81.05
Ch15y	-60.68
Ch1m	-4.13
Ch1w	4.51
Ch1y	-12.12
Ch20y	625
Ch3m	-22.15
Ch3y	-28.4
Ch5y	-74.51
Ch6m	-35.56
Change	1.75%
Change From Open	1.75
Close	1.14
Days Gap	0
Depreciation Amortization	87,758,000
Dollar Volume	652,500
Earnings Date	2026-03-30
EBIT	HKD 110.3M
EBITDA	HKD 198M
EPS	HKD 0.16
F Score	5
FCF	HKD 266.3M
FCF EV Yield	53.48x
FCF Per Share	HKD 0.45
Financing CF	35,583,000
Fiscal Year End	December
Founded	1,994
Goodwill	3,900,000
Graham Number	3.49323
Graham Upside	201.1
Income Tax	HKD 22.3M
Investing CF	-235,765,000
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	HKD 2.93
Lynch Upside	152.3
Ma150	1.59
Ma150ch	-27%
Ma20	1.17
Ma20ch	-0.85%
Net CF	128,603,000
Open	1.14
P FCF Ratio	2.57
P OCF Ratio	2.05
Payment Date	2026-06-15
Position In Range	100
Ppne	384,727,000
Price Date	2026-05-08
Price EBITDA	HKD 3.45
Ptbv Ratio	0.39
Relative Volume	0.86x
Revenue	1,435,980,000x
SBC By Revenue	0.04x
Share Based Comp	515,000
Tax By Revenue	1.55x
Tax Rate	30.55%
Tr20y	879.6%
Tr6m	-35.56%
Volume	562,500
Z Score	2.4

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/0950 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.9%

$0.04 annual per share

Payout ratio

+30.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-4.9%

2 consecutive years of growth

Total shareholder yield

+3.8%

Next ex-dividend date: 2026-05-27

Performance

HKG/0950 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/0950?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.0%

Share of float held by funds and institutions

Insider ownership

+11.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

HKG/0950 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

-31.1%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/0950

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0950 stock rating?

hkg/0950 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0950 analysis?

The full report lives at /stocks/hkg/0950/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0950?

The latest report frames hkg/0950 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0950 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.